Regulation of the β1,4-Galactosyltransferase i promoter by E2F1

Journal of Biochemistry

Volumn 148, Issue 3, 2010, Pages 263-271

  Wei, Yuanyan ^a   Zhou, Fengbiao ^a   Ge, Yuqing ^a   Chen, Hong ^a   Cui, Chunhong ^a   Liu, Dan ^a   Yang, Zhiyuan ^a   Wu, Guoqiang ^a   Shen, Jialin ^a   Gu, Jianxin ^a   Jiang, Jianhai ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

1,4 galactosyltransferase I; cell cycle; E2F1; promoter; transcriptional regulation

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE I; CELL SURFACE PROTEIN; CYCLIN D1; MESSENGER RNA; N ACETYLGLUCOSAMINE; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; BETA-1,4-GALACTOSYLTRANSFERASE I; GALACTOSYLTRANSFERASE;

ARTICLE; CELL CYCLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; MUTAGENESIS; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY MECHANISM; BINDING SITE; CELL LINE; GENE EXPRESSION REGULATION; GENETICS;

MAMMALIA;

BINDING SITES; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE; E2F1 TRANSCRIPTION FACTOR; GALACTOSYLTRANSFERASES; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC;

EID: 77956442326     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvq061     Document Type: Article

References (54)

1. Taniguchi, N., Ihara, S., Saito, T., Miyoshi, E., Ikeda, Y., and Honke, K. (2001) Implication of GnT-V in cancer metastasis: a glycomic approach for identification of a target protein and its unique function as an angiogenic cofactor. Glycoconj. J. 18, 859-865
2. Taniguchi, N., Miyoshi, E., Ko, J.H., Ikeda, Y., and Ihara, Y. (1999) Implication of Nacetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochim. Biophys. Acta. 1455, 287-300
3. Kotani, N., Asano, M., Iwakura, Y., and Takasaki, S. (2001) Knockout of mouse beta 1,4- galactosyltransferase-1 gene results in a dramatic shift of outer chain moieties of N-glycans from type 2 to type 1 chains in hepatic membrane and plasma glycoproteins. Biochem. J. 357, 827-834
4. Furukawa, K. and Sato, T. (1999) Beta-1,4- galactosylation of N-glycans is a complex process. Biochim. Biophys. Acta. 1473, 54-66
5. Furukawa, K. and Kobata, A. (1991) IgG galactosylation - its biological significance and pathology. Mol. Immunol. 28, 1333-1340
6. Hinton, D.A., Evans, S.C., and Shur, B.D. (1995) Altering the expression of cell surface beta 1,4-galactosyltransferase modulates cell growth. Exp. Cell Res. 219, 640-649
7. Gao, Y., Miyazaki, J., and Hart, G.W. (2003) The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells. Arch. Biochem. Biophys. 415, 155-163
8. Abdel-Motal, U., Wang, S., Lu, S., Wigglesworth, K., and Galili, U. (2006) Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes. J. Virol. 80, 6943-6951
9. Yamashita, K., Taketa, K., Nishi, S., Fukushima, K., and Ohkura, T. (1993) Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. Cancer Res. 53, 2970-2975
10. Gong, X., Dubois, D.H., Miller, D.J., and Shur, B.D. (1995) Activation of a G protein complex by aggregation of beta-1,4-galactosyltransferase on the surface of sperm. Science 269, 1718-1721
11. Maillet, C.M. and Shur, B.D. (1994) Perturbing cell surface beta-(1,4)-galactosyltransferase on F9 embryonacarcinoma cells arrests cell growth and induces laminin synthesis. J. Cell Sci. 107 (Pt 6), 1713-1724
12. Steffgen, K., Dufraux, K., and Hathaway, H. (2002) Enhanced branching morphogenesis in mammary glands of mice lacking cell surface beta1, 4-galactosyltransferase. Dev. Biol. 244, 114-133
13. Asano, M., Furukawa, K., Kido, M., Matsumoto, S., Umesaki, Y., Kochibe, N., and Iwakura, Y. (1997) Growth retardation and early death of beta-1, 4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J. 16, 1850-1857
14. Kotani, N., Asano, M., Iwakura, Y., and Takasaki, S. (1999) Impaired galactosylation of core 2 O-glycans in erythrocytes of beta1,4- galactosyltransferase knockout mice. Biochem. Biophys. Res. Commun. 260, 94-98
15. Mori, R., Kondo, T., Nishie, T., Ohshima, T., and Asano, M. (2004) Impairment of skin wound healing in beta-1,4-galactosyltransferase-deficient mice with reduced leukocyte recruitment. Am. J. Pathol. 164, 1303-1314
16. Penno, M.B., Passaniti, A., Fridman, R., Hart, G.W., Jordan, C., Kumar, S., and Scott, A.F. (1989) In vitro galactosylation of a 110-kDa glycoprotein by an endogenous cell surface galactosyltransferase correlates with the invasiveness of adrenal carcinoma cells. Proc. Natl Acad. Sci., USA 86, 6057-6061
17. Johnson, F.M. and Shur, B.D. (1999) The level of cell surface beta1,4-galactosyltransferase I influences the invasive potential of murine melanoma cells. J. Cell Sci. 112 (Pt 16), 2785-2795
18. Zhu, X., Jiang, J., Shen, H., Wang, H., Zong, H., Li, Z., Yang, Y., Niu, Z., Liu, W., Chen, X., Hu, Y., and Gu, J. (2005) Elevated beta1,4- galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator. J. Biol. Chem. 280, 12503-12516
19. Yamashita, H., Kubushiro, K., Ma, J., Fujii, T., Tsukazaki, K., Iwamori, M., and Nozawa, S. (2003) Alteration in the metastatic potential of ovarian cancer cells by transfection of the antisense gene of beta-1, 4-galactosyltransferase. Oncol. Rep. 10, 1857-1862
20. Masibay, A.S., Damewood, G.P., Boeggeman, E., and Qasba, P.K. (1991) Expression of beta-1, 4-galactosyltransferase gene during 3T3 cell growth. Biochim. Biophys. Acta. 1090, 230-234
21. Zhang, S.W., Fu, X.Y., Cao, S.L., Shen, Z.H., and Gu, J.X. (1999) Down-regulation of beta1, 4-galactosyltransferase gene expression by cell-cycle suppressor gene p16. Biochim. Biophys. Acta. 1444, 49-54
22. Zhang, S.W., Lin, W.S., Ying, X.L., Zhu, D., Guo, M.Y., and Gu, J.X. (2000) Effect of suppression of TGF-beta1 expression on cell-cycle and gene expression of beta-1,4-galactosyltransferase 1 in human hepatocarcinoma cells. Biochem. Biophys. Res. Commun. 273, 833-838
23. Iaquinta, P.J. and Lees, J.A. (2007) Life and death decisions by the E2F transcription factors. Curr. Opin. Cell Biol. 19, 649-657
24. Wu, Z., Zheng, S., and Yu, Q. (2009) The E2F family and the role of E2F1 in apoptosis. Int. J. Biochem. Cell Biol. 41, 2389-2397
25. Ahlander, J. and Bosco, G. (2009) The RB/E2F pathway and regulation of RNA processing. Biochem. Biophys. Res. Commun. 384, 280-283
26. Polager, S. and Ginsberg, D. (2008) E2F - at the crossroads of life and death. Trends Cell Biol. 18, 528-535
27. Blais, A. and Dynlacht, B.D. (2007) E2F-associated chromatin modifiers and cell cycle control. Curr. Opin. Cell Biol. 19, 658-662
28. Conner, E.A., Lemmer, E.R., Omori, M., Wirth, P.J., Factor, V.M., and Thorgeirsson, S.S. (2000) Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene. 19, 5054-5062
29. Yoon, S.O., Shin, S., and Mercurio, A.M. (2006) Ras stimulation of E2F activity and a consequent E2F regulation of integrin alpha6beta4 promote the invasion of breast carcinoma cells. Cancer Res. 66, 6288-6295
30. Yamasaki, L., Bronson, R., Williams, B.O., Dyson, N.J., Harlow, E., and Jacks, T. (1998) Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(/-)mice. Nat. Genet. 18, 360-364
31. Tsai, K.Y., Hu, Y., Macleod, K.F., Crowley, D., Yamasaki, L., and Jacks, T. (1998) Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell. 2, 293-304
32. Wang, Q., Sun, Z., and Yang, H.S. (2008) Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells. Oncogene. 27, 1527-1535
33. Jiang, J., Shen, J., Wu, T., Wei, Y., Chen, X., Zong, H., Zhang, S., Sun, M., Xie, J., Kong, X., Yang, Y., Shen, A., Wang, H., and Gu, J. (2006) Down-regulation of beta1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells. Glycobiology. 16, 1045-1051
34. Jiang, J., Chen, X., Shen, J., Wei, Y., Wu, T., Yang, Y., Wang, H., Zong, H., Yang, J., Zhang, S., Xie, J., Kong, X., Liu, W., and Gu, J. (2006) Beta1,4- galactosyltransferase V functions as a positive growth regulator in glioma. J. Biol. Chem. 281, 9482-9489
35. Ma, Y., Yuan, J., Huang, M., Jove, R., and Cress, W.D. (2003) Regulation of the cyclin D3 promoter by E2F1. J. Biol. Chem. 278, 16770-16776
36. Gao, G., Bracken, A.P., Burkard, K., Pasini, D., Classon, M., Attwooll, C., Sagara, M., Imai, T., Helin, K., and Zhao, J. (2003) NPAT expression is regulated by E2F and is essential for cell cycle progression. Mol. Cell. Biol. 23, 2821-2833
37. Diehl, J.A. (2002) Cycling to cancer with cyclin D1. Cancer Biol. Ther. 1, 226-231
38. Schmidt, A., Kuhla, B., Bigl, K., Munch, G., and Arendt, T. (2007) Cell cycle related signaling in Neuro2a cells proceeds via the receptor for advanced glycation end products. J. Neural. Transm. 114, 1413-1424
39. Munz, M., Fellinger, K., Hofmann, T., Schmitt, B., and Gires, O. (2008) Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM. Front. Biosci. 13, 5195-5201
40. Andre, S., Sanchez-Ruderisch, H., Nakagawa, H., Buchholz, M., Kopitz, J., Forberich, P., Kemmner, W., Bock, C., Deguchi, K., Detjen, K.M., Wiedenmann, B., von Knebel Doeberitz, M., Gress, T.M., Nishimura, S., Rosewicz, S., and Gabius, H.J. (2007) Tumor suppressor p16INK4a-modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydratedependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 274, 3233-3256
41. Olden, K. (1993) Adhesion molecules and inhibitors of glycosylation in cancer. Sem. Cancer Biol. 4, 269-276
42. Glinsky, G.V. (1994) Antigen presentation, aberrant glycosylation and tumor progression. Crit. Rev. Oncol. Hemat. 17, 27-51
43. Dennis, J.W., Granovsky, M., and Warren, C.E. (1999) Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta. 1473, 21-34
44. Chou, T.Y. and Hart, G.W. (2001) O-linked N-acetylglucosamine and cancer: messages from the glycosylation of c-Myc. Adv. Exp. Med. Biol. 491, 413-418
45. Zhao, Y.Y., Takahashi, M., Gu, J.G., Miyoshi, E., Matsumoto, A., Kitazume, S., and Taniguchi, N. (2008) Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 99, 1304-1310
46. Gu, J., Sato, Y., Kariya, Y., Isaji, T., Taniguchi, N., and Fukuda, T. (2009) A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. J. Proteome Res. 8, 431-435
47. Gu, J., Isaji, T., Sato, Y., Kariya, Y., and Fukuda, T. (2009) Importance of N-glycosylation on alpha5beta1 integrin for its biological functions. Biol. Pharm. Bull. 32, 780-785
48. Zhou, D., Chen, C., Jiang, S., Shen, Z., Chi, Z., and Gu, J. (1998) Expression of beta1,4-galactosyltransferase in the development of mouse brain. Biochim. Biophys. Acta. 1425, 204-208
49. Hansske, B., Thiel, C., Lubke, T., Hasilik, M., Honing, S., Peters, V., Heidemann, P.H., Hoffmann, G.F., Berger, E.G., von Figura, K., and Korner, C. (2002) Deficiency of UDP-galactose:N-acetylglucosamine beta-1, 4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J. Clin. Invest. 109, 725-733 (Pubitemid 34263149)
50. Lo, N.W., Shaper, J.H., Pevsner, J., and Shaper, N.L. (1998) The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiology 8, 517-526
51. Day, M.L., Foster, R.G., Day, K.C., Zhao, X., Humphrey, P., Swanson, P., Postigo, A.A., Zhang, S.H., and Dean, D.C. (1997) Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/ E2F pathway. J. Biol. Chem. 272, 8125-8128
52. Nevins, J.R. (1992) E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258, 424-429
53. Markey, M., Siddiqui, H., and Knudsen, E.S. (2004) Geminin is targeted for repression by the retinoblastoma tumor suppressor pathway through intragenic E2F sites. J. Biol. Chem. 279, 29255-29262
54. OConnor, R.J., Schaley, J.E., Feeney, G., and Hearing, P. (2001) The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters. Oncogene. 20, 1882-1891